Goldman, Butterwick, Fitzpatrick and Groff
Goldman, Butterwick, Fitzpatrick and Groff
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms | Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, alveolar rhabdomyosarcoma, myomatous neoplasm, neoplasm, rhabdomyosarcoma, sarcoma | Not yet recruiting | Phase 2 / Phase 3 | 2026-07-07 | NCT07686198 | |
| Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist | Body Weight, Body Weight Changes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Weight Loss, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Not applicable | 2026-04-30 | NCT07558603 | |
| Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Facies, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Phase 2 | 2026-03-10 | NCT07462533 | |
| Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines | Facial Laxity; Fine Lines; Volume Loss; Wrinkle | Not yet recruiting | Phase 4 | 2026-02-19 | NCT07421544 | |
| Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias | Leg Veins | Not yet recruiting | Phase 4 | 2026-01-15 | NCT07342413 | |
| Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Phase 2 | 2025-10-28 | NCT07221461 | |
| Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging | Body Weight, Body Weight Changes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Weight Loss, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Not applicable | 2025-10-28 | NCT07216352 | |
| Assess Impact of Poly-L-lactic Acid on GLP1 Subjects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Phase 2 | 2025-10-16 | NCT07217743 | |
| Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH: Split-Body Randomized Clinical Trial of Poly-L-Lactic Acid for Adipogenesis and Volumization of the Hip Dell" Study | Lateral Gluteal Depression | Active, not recruiting | Not stated | 2025-04-18 | NCT06656923 | |
| 1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss | Female Pattern Baldness, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Not applicable | 2025-04-16 | NCT06926023 | |
| Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin | Facial Wrinkles; Skin Aging | Not yet recruiting | Phase 2 / Phase 3 | 2024-10-15 | NCT06638905 |